Biostar Receives Approval for Advertising of Hepatitis B Drug in Shaanxi Province

Drugmaker Biostar Pharmaceuticals said Tuesday it received new marketing approval for an over-the-counter hepatitis B drug, its main product, in China’s Shaanxi province.
CB Online